Maple Rock Capital Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.8M Buy
344,800
+172,100
+100% +$35.3M 1.95% 18
2025
Q4
$44.2M Sell
172,700
-110,600
-39% -$29M 1.46% 22
2025
Q3
$73.7M Buy
283,300
+178,756
+171% +$47M 2.91% 12
2025
Q2
$25.6M Sell
104,544
-7,786
-7% -$1.94M 1.25% 29
2025
Q1
$29.7M Buy
+112,330
New +$30.4M 1.09% 26

Other funds holding HUM

Maple Rock Capital Partners's HUM Position: Q1 2026 in Review

Maple Rock Capital Partners increased its Humana (HUM) stake by 100% in Q1 2026, buying an estimated $35.3M and bringing the position to 344,800 shares worth $59.8M. The position accounts for 1.95% of the portfolio, ranked #18.

Maple Rock Capital Partners first reported a position in HUM in Q1 2025 and has held it in 5 quarters since. The position peaked at $73.7M in Q3 2025. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Maple Rock Capital Partners held 344,800 shares of Humana worth $59.8M as of Q1 2026.
  • Maple Rock Capital Partners bought 172,100 Humana shares in Q1 2026, an estimated $35.3M.
  • Humana made up 1.95% of Maple Rock Capital Partners's portfolio in Q1 2026, its #18 holding.
  • Maple Rock Capital Partners first reported a position in Humana in Q1 2025 and has held it in 5 quarters since.
  • Maple Rock Capital Partners's Humana position peaked at $73.7M in Q3 2025.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Maple Rock Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.